To provide additional transparency on the App Store, apps that are available in the European Union (EU)/European Economic Area (EEA), United Kingdom (UK), or United States (US), and that also meet either of the criteria listed below must indicate whether they’re regulated medical device with respect to each region’s regulatory authority or body responsible for the governance and compliance of medical devices.
Examines the increasing strain on caregivers in home-based care models, the level of support they need for various stages of care, and how improved technological devices and infrastructure can help alleviate their burden.
The rise of AI-powered health apps that claim to diagnose conditions in real time is transforming how we approach healthcare. From symptom checkers to wearable ECG monitors and AI stethoscope apps, these tools promise early diagnoses and personalized healthcare at our fingertips. What if they go wrong?
A comprehensive update on the combination products market shows significant industry partnerships, development challenges, and strategic imperatives for success in the sector characterized by dynamic collaboration between pharmaceutical and device companies, rapid product development cycles, and complex regulatory landscapes.
Increasing patient demand, barriers to access, and elevated costs are pushing healthcare providers to reconsider traditional clinical and operational workflows to meet growing challenges and improve patient outcomes. Artificial intelligence (AI), robotics, and digital therapeutic solutions are streamlining processes and expanding the possibilities for reimagining care delivery. As these technologies converge, the shift from complex high-cost interventions toward lighter more adaptive care models creates opportunity to better meet the needs of diverse patient populations.
Up until now, the lack of interoperable health-at-home devices has inhibited health technology integration into the home for use in wellness, prevention, managing chronic conditions, and clinical trials.
Continuous glucose monitoring (CGM) technology is rapidly expanding beyond Type 1 diabetes to reach a wider demographic, including Type 2 diabetics and wellness users. How manufacturers advancing CGM technology to address these diverse needs, focusing on ease of use, device reliability, and adherence strategies? By prioritizing these areas, manufacturers can empower a growing user base to manage their health more effectively and independently.
Wearables such as smart watches or sensor rings are already a routine part of everyday life and are also popular Christmas gifts. They track our pulse rate, count our steps or analyze our sleep patterns. How can they already influence our behavior today and what future developments are possible?
The integration of technology and connectivity into healthcare is not only improving patient outcomes but also reshaping the way care is delivered.
AI and real-time data enhance care efficiency and access. And with healthcare workers in short supply, the rapid advancements in AI, IoMT, and related innovation offer patient access freedom, enhanced care delivery, and better outcomes.
